Companies related to immuno-oncology

Bringing context to biology and human health through spatial phenotyping — we are The Spatial Biology Company®. 🥼🧬

Conquering Cancer

This page is no longer active. Please follow us at Labcorp Drug Development.

Biond - Innovative immunotherapies and a pioneering intracellular delivery for biologics for the treatment of patients

Developing Innovative Cell Therapies Against Cancer

We are in the business of extending life for patients.

Founded in 1953, CRI is the world's leading nonprofit dedicated to funding cancer immunotherapy research.

The Eurofins Discovery Products Company

In Pursuit of Answers

Genomics for better health

Leading, late clinical-stage nanomedicine company pioneering new approaches to significantly change patient outcomes.

A clinical-stage cancer immunotherapy company and a pioneer in computational target discovery

Personalizing Precision Oncology

Unlocking the future of medicine

LEADING THE WAY FROM BASIC TO APPLIED INNOVATIVE RESEARCH

LEADING THE WAY FROM BASIC TO APPLIED INNOVATIVE RESEARCH

We’re revolutionizing #cancercare through #IL2 therapeutics designed to direct the #immunesystem to destroy cancers.

Harnessing Innate and Adaptive Immune Responses to Cure Disease.

Decoding Biology to Radically Improve Lives

Oncology company developing Biclonics® bispecific antibody therapeutics. See our Community Guidelines: http://bit.ly/36c

Leading a new way to fight cancer

Let's Build Better Cells Together

A Member of the Roche Group

Creating neoantigens by design -- to transform cancer treatments into cures

Pioneer in living medicines

Improving patient outcomes with AI-powered pathology.

A preclinical-stage biotech focusing on oncology and immunology

Transcend The Conventional

A new frontier in the fight against cancer– the right activation of the right immune cells

#biopharma #biotech #drugdiscovery #GPCR #Immunooncology #inflammation

Bringing Effective New Treatments And Options To Patients Who Need Them

Novel human immunomodulatory proteins for cancer and autoimmune diseases with a specific role in innate immunity

Iovance is a patient-centric, collaborative organization that is driven to change the way cancer is treated.

Great Science Deserves Great People.

Smart Clinical Operations. Tailored partnerships. Real results.

Agilex Biolabs is Australia’s Largest and Most Technologically Advanced Biolab with Global Reach

Engineered Immunity

Pioneering thymus-empowered T-cell platform to fight cancer and infection

Powering the next generation in bioelectric medicine with Nanosecond Pulsed Field Ablation technology.

Any Assay, Anywhere, Any Area. A Global Leader for Services in Drug R&D Enabling.

From promising to validated immuno-therapeutics: GEM design and humanization, profiling solutions for your candidate

New therapies for inflammatory disease and cancer by targeting fibroblast immunology

Unlocking targeted medicines with our transformative mRNA platform

Fate can be altered.

Developing a portfolio of immune-educating therapies based on our DPX® platform to treat solid and hematologic cancers

Targeted delivery of nanoparticles for in vivo CAR T therapy

Advancing Immunotherapy with Novel Antigen Discovery

Best-in-class treatment of HPV-cancer

We provide drug developers with high-quality data to give them the confidence to take their drug discovery forward.

Attacking Bladder Cancer for a Better Tomorrow

Human translational data early - We help you bridge the safety and dosing gap between pre-clinical & clinical studies

Pioneering A New Class of Universal Vaccines

"Turn breakthroughs into success with Snow Leopard Consulting's innovative, cost-effective preclinical solutions." ©️

At your side to pioneer immuno-oncology therapies

Supercharging Immunotherapy

evaxion.ai

We are developing next-generation antibodies into transformative cancer therapies that improve patients’ lives.

Macrophage Biology Revealed:Developing breakthrough approaches to macrophage activity to change the course of disease

REDEFINING ANTIBODY THERAPIES

Pioneering DARPin Therapeutics for Patients

AI-powered precision diagnostics for pathology

Virotherapy to Ignite Immunotherapy

Developing Biotechnology Solutions That Transforms Lives | Clinical Research | Bioanalytical & Drug Development

Accelerating Drug Development with R&D Services Driven by Science and Technology

Developing transformative medicines in neuroscience using artificial intelligence approaches

An off-the-shelf multimodal biological immunotherapy company empowering the patient's immune system to fight cancer.

ImmuNext develops compounds on the cutting edge of immunotherapy for cancer and autoimmune diseases.

is developing disruptive therapies to address critical unmet medical needs in cancer and infectious diseases.

Harnessing the Power of Natural Killer Cells

Engineering the future of targeting Natural Killer off-the-shelf cell therapy against cancer.

Our expertise, Your discovery

Your key partner for breakthrough antibody discovery

Driven by Immunology in the Pursuit of Powerful Prevention and Treatment of Disease

A global leader in bispecific antibody therapeutics for immuno-oncology and neurodegenerative diseases.

A leading Immuno Oncology company in the space of NK cell therapeutics

We transform lives by inspiring science & leading innovation.

Innovative clinical trial solutions

A fully integrated biotech company at the forefront of pioneering cutting-edge immunotherapies.

Discovering drugs that create neoantigens

Discover the Hidden Variables that Predict Patient Response

On a quest to leverage the power of single cell genomics to discover novel drug targets and precision therapeutics.

Saving Lives Through Innovation

We understand disease through the lens of the immune system for more effective, safer treatments & better diagnosis.

We are in the business of extending life for patients.

Altevax is developing a disruptive immunotherapy technology against cancer

Clinical-stage biotech company developing drugs that harness glyco-immunology to treat cancer and inflammatory diseases

Committed to delivering effective TCR cancer therapies. Striving towards a cure.

Deep Immune Phenotyping & MultiOmics DataScience, for immune precision medicine

A specialty oncology CRO and a pioneer in immunotherapy studies.

Your partner in immunology projects!

The KREX™ platform delivers precision antibody profiling with correctly folded, highly multiplexed proteins.

MAKING THE INVISIBLE VISIBLE IN THE FIGHT AGAINST CANCER

TiumBio is committed to developing innovative therapeutics for patients with rare or incurable diseases

An advanced-clinical-stage biotechnology company developing dendritic cell therapies to treat cancer

Maximizing immune integrity through the development of unique natural killer (NK) cell therapies.

Visibility to Immuno-Oncology & Lymphocyte Enhancing Therapies